ʻO ka PCR Fluorescence
-
ʻAno maʻi polio Ⅰ
He kūpono kēia pahu no ka ʻike qualitative o ka poliovirus type I nucleic acid i nā laʻana o ka noho kanaka in vitro.
-
ʻAno maʻi polio Ⅱ
He kūpono kēia kit no ka ʻike qualitative o ka poliovirus Type Ⅱnucleic acid i loko o nā kumu hoʻohālike kanaka i loko o ka vitro.
-
Enterovirus 71 (EV71)
Ua manaʻo ʻia kēia pahu no ka ʻike in vitro qualitative o enterovirus 71 (EV71) nucleic acid i loko o nā swabs oropharyngeal a me nā mea hoʻohālike wai herpes o nā maʻi me ka maʻi lima-wāwae-waha.
-
Enterovirus Universal
Hoʻolālā ʻia kēia huahana no ka ʻike in vitro qualitative o enteroviruses i loko o nā swabs oropharyngeal a me nā hōʻailona wai o ka herpes. ʻO kēia pahu no ke kōkua i ka hōʻoia ʻana i ka maʻi lima-wāwae-waha.
-
ʻO Herpes Simplex Virus Type 1
Hoʻohana ʻia kēia kime no ka ʻike qualitative o Herpes Simplex Virus Type 1 (HSV1).
-
ʻO Chlamydia Trachomatis, Neisseria Gonorrhoeae a me Trichomonas vaginalis
Kuhi ʻia ka pahu no ka ʻike in vitro qualitative o Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG)aʻO Trichomonal vaginitis (TV) i loko o ke kane urethral swab, wahine cervical swab, a me ka wahine vaginal swab samples, a hāʻawi i ke kōkua i ka ʻike a me ka mālama ʻana i nā maʻi me nā maʻi maʻi genitourinary.
-
ʻO Trichomonas Vaginalis Nucleic Acid
Hoʻohana ʻia kēia kit no ka ʻike qualitative o Trichomonas vaginalis nucleic acid i loko o nā laʻana huna huna urogenital kanaka.
-
Hoʻohui ʻia nā mea maʻi hanu
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o nā pathogens hanu i loko o ka waikawa nucleic i unuhi ʻia mai nā laʻana oropharyngeal swab kanaka.
Hoʻohana ʻia kēia kumu hoʻohālike no ka ʻike qualitative o 2019-nCoV, influenza A virus, influenza B virus a me respiratory syncytial virus nucleic acids i loko o nā mea hoʻohālike swab oropharyngeal kanaka.
-
Hoʻohui ʻia nā mea maʻi hanu
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o ka maʻi maʻi influenza A, ka maʻi influenza B, ka maʻi hanu syncytial, adenovirus, ka rhinovirus kanaka a me ka mycoplasma pneumoniae nucleic acids i loko o nā swabs nasopharyngeal kanaka a me nā mea hoʻohālike oropharyngeal swab. Hiki ke hoʻohana ʻia nā hopena hoʻāʻo no ke kōkua ʻana i ka ʻike ʻana i nā maʻi pathogen respiratory, a hāʻawi i ke kumu diagnostic molecular auxiliary no ka ʻike a me ka mālama ʻana i nā maʻi pathogen respiratory.
-
14 Nā ʻano o ka maʻi maʻi maʻi maʻi Genitourinary
Kuhi ʻia ka pahu no ka ʻike in vitro qualitative o Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes simplex virus type 1 (HSV1), Ureaplasma urealyticum (UU), Herpes simplex virus type 2 (HSV2), Ureaplasma parvum (UP), Ureaplasma parvum (UP), Ureaplasma parvum (UP) (CA), Gardnerella vaginalis (GV), Trichomonal vaginitis (TV), Group B streptococci (GBS), Haemophilus ducreyi (HD), a me Treponema pallidum (TP) i loko o ka mimi, male urethral swab, wahine cervical swab, a me ka wahine vaginal swab samples, a hāʻawi i ke kōkua i ka hōʻailona a me ka mālama ʻana i nā maʻi me ka maʻi genitourinary.
-
SARS-CoV-2/influenza A/influenza B
He kūpono kēia kit no ka ʻike in vitro qualitative o SARS-CoV-2, influenza A a me ka influenza B nucleic acid o ka nasopharyngeal swab a me nā oropharyngeal swab samples o ka poʻe i manaʻo ʻia i ka maʻi o SARS-CoV-2, influenza A a me ka maʻi influenza B. Hiki ke hoʻohana ʻia i ka poʻe maʻi a me ka qualitative influenza detection a me ka qualitative influenza-CoV detection a me ka qualitative influenza. a me ka influenza B nucleic acid i loko o ka nasopharyngeal swab a me ka oropharyngeal swab samples o ka maʻi Coronavirus hou ma nā kūlana ʻē aʻe.
-
18 Nā ʻano o ke kanaka papilloma virus nucleic acid kiʻekiʻe
He mea kūpono kēia pahu no ka ʻike in vitro qualitative o 18 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 66, 68, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56. mimi kāne/wahine a me nā pūnaeau exfoliated cervical wahine a me ke kikokiko HPV 16/18.